Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WX-G250 and WX-G250RIT designated orphan drugs for renal cell carcinoma in E.U.

April 9, 2002

Inhibitors of uPA with favorable PK properties described in patent literature

April 9, 2002

Preclinical data discussed this week support clinical trials with thioplatin

April 9, 2002

European Commission designates E21R orphan drug in JMML

April 9, 2002

Adherex and AstraZeneca extend Exherin collaboration agreement

April 9, 2002

Independent review and long-term follow-up of phase II Orathecin study

April 9, 2002

Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting

April 9, 2002

Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131

April 9, 2002

Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium

April 9, 2002

LAQ-824: a potential new antitumor agent acting via inhibition of histone deacetylase

April 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026